{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:21:02Z","timestamp":1792102862599,"version":"4.4.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Technology Innovation Program","award":["10060067"],"award-info":[{"award-number":["10060067"]}]},{"name":"Technical development of nanosystem-based technology for drug therapy preventing side effects after cataract surgery"},{"name":"Ministry of Trade"},{"name":"Bio & Medical Technology Development Program of the National Research Foundation funded by the Ministry of Science"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.ijpharm.2017.02.035","type":"journal-article","created":{"date-parts":[[2017,2,17]],"date-time":"2017-02-17T02:00:56Z","timestamp":1487296856000},"page":"66-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Enhanced ocular efficacy of topically-delivered dorzolamide with nanostructured mucoadhesive microparticles"],"prefix":"10.1016","volume":"522","author":[{"given":"Chun Gwon","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Kook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se-Na","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beom Kang","family":"Huh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-A","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyein","family":"Won","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki Ho","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Bin","family":"Choy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2017.02.035_bib0005","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jddst.2016.03.011","article-title":"Influence of hydroxypropylmethylcellulose and poloxamer composite on developed ophthalmic in situ gel: ex vivo and in vivo characterization","volume":"33","author":"Barse","year":"2016","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ijpharm.2017.02.035_bib0010","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1517\/13543776.2012.649006","article-title":"Novel therapies for glaucoma: a patent review 2007\u20132011","volume":"22","author":"Carta","year":"2012","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ijpharm.2017.02.035_bib0015","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S0149-2918(01)80109-0","article-title":"A systematic review of the associations between dose regimens and medication compliance","volume":"23","author":"Claxton","year":"2001","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ijpharm.2017.02.035_bib0020","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nnano.2007.223","article-title":"Immunological properties of engineered nanomaterials","volume":"2","author":"Dobrovolskaia","year":"2007","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.ijpharm.2017.02.035_bib0025","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1039\/c2cs15327k","article-title":"Design of polymeric nanoparticles for biomedical delivery applications","volume":"41","author":"Elsabahy","year":"2012","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ijpharm.2017.02.035_bib0030","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1517\/17425247.3.2.275","article-title":"Ocular drug delivery","volume":"3","author":"Ghate","year":"2006","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2017.02.035_bib0035","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1089\/jop.2013.0060","article-title":"\u03b3-Cyclodextrin nanoparticle eye drops with dorzolamide: effect on intraocular pressure in man","volume":"30","author":"Gudmundsdottir","year":"2014","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.ijpharm.2017.02.035_bib0040","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1586\/17469899.2014.892415","article-title":"Neuroprotection in glaucoma: current and emerging approaches","volume":"9","author":"Hanumunthadu","year":"2014","journal-title":"Expert Rev. Ophthalmol."},{"key":"10.1016\/j.ijpharm.2017.02.035_bib0045","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S0161-6420(03)00075-7","article-title":"Hypertension, diabetes, and longitudinal changes in intraocular pressure","volume":"110","author":"Hennis","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ijpharm.2017.02.035_bib0050","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ejpb.2015.06.001","article-title":"Dual drug delivery from vitamin E loaded contact lenses for glaucoma therapy","volume":"94","author":"Hsu","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2017.02.035_bib0055","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1248\/yakushi.121.799","article-title":"Evaluation and multivariate statistical analysis of factors influencing patient adherence to ophthalmic solutions","volume":"121","author":"Ikeda","year":"2001","journal-title":"Yakugaku Zasshi"},{"key":"10.1016\/j.ijpharm.2017.02.035_bib0060","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/ajhp\/62.7.691","article-title":"Glaucoma and its treatment: a review","volume":"62","author":"Lee","year":"2005","journal-title":"Am. J. Health. Syst. Pharm."},{"key":"10.1016\/j.ijpharm.2017.02.035_bib0065","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0168-3659(01)00218-8","article-title":"PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats","volume":"71","author":"Li","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2017.02.035_bib0070","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1755-3768.2011.02299.x","article-title":"Topical drug delivery to the eye: dorzolamide","volume":"90","author":"Loftsson","year":"2012","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.ijpharm.2017.02.035_bib0075","series-title":"Classification of Artificial Tears, Lacrimal Gland, Tear Film, and Dry Eye Syndromes 2","first-page":"693","author":"Murube","year":"1998"},{"key":"10.1016\/j.ijpharm.2017.02.035_bib0080","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijpharm.2012.10.014","article-title":"Polymeric nanoparticles augment the ocular hypotensive effect of melatonin in rabbits","volume":"440","author":"Musumeci","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2017.02.035_bib0085","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archopht.121.6.856","article-title":"Factors related to the 4-year risk of high intraocular pressure: the Barbados Eye Studies","volume":"121","author":"Nemesure","year":"2003","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.ijpharm.2017.02.035_bib0090","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2174\/1567201811310030004","article-title":"Preparation of a molecularly imprinted soft contact lens as a new ocular drug delivery system for dorzolamide","volume":"10","author":"Nikouei","year":"2013","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2017.02.035_bib0095","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/clpt.2008.297","article-title":"Ophthalmic drug delivery: development and regulatory considerations","volume":"85","author":"Novack","year":"2009","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ijpharm.2017.02.035_bib0100","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1517\/17425240902762818","article-title":"Chitosan nanoparticles for drug delivery to the eye","volume":"6","author":"Paolicelli","year":"2009","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2017.02.035_bib0105","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.carbpol.2007.11.007","article-title":"Chitosan nanoparticles loaded with dorzolamide and pramipexole","volume":"73","author":"Papadimitriou","year":"2008","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ijpharm.2017.02.035_bib0110","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.actbio.2013.08.026","article-title":"Nanostructured mucoadhesive microparticles for enhanced preocular retention","volume":"10","author":"Park","year":"2014","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ijpharm.2017.02.035_bib0115","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jconrel.2015.10.027","article-title":"Mucoadhesive microparticles with a nanostructured surface for enhanced bioavailability of glaucoma drug","volume":"220","author":"Park","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2017.02.035_bib0120","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0928-0987(02)00057-X","article-title":"Eudragit RS100\u00ae nanosuspensions for the ophthalmic controlled delivery of ibuprofen","volume":"16","author":"Pignatello","year":"2002","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2017.02.035_bib0125","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bjo.2005.081224","article-title":"The number of people with glaucoma worldwide in 2010 and 2020","volume":"90","author":"Quigley","year":"2006","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ijpharm.2017.02.035_bib0130","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0140-6736(10)61423-7","article-title":"Glaucoma","volume":"377","author":"Quigley","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ijpharm.2017.02.035_bib0135","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1016\/j.xphs.2016.06.023","article-title":"Novel polymeric nanoparticles intended for ophthalmic administration of acetazolamide","volume":"105","author":"Quinteros","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2017.02.035_bib0140","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2147\/PPA.S23780","article-title":"Objective assessment of compliance and persistence among patients treated for glaucoma and ocular hypertension: a systematic review","volume":"5","author":"Reardon","year":"2011","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.ijpharm.2017.02.035_bib0145","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/jbm.b.32842","article-title":"Biodegradable internal fixation plates enabled with X-ray visibility by a radiopaque layer of \u03b2-tricalcium phosphate and poly (lactic-co-glycolic acid)","volume":"101","author":"Shasteen","year":"2013","journal-title":"J. Biomed. Mater. Res. Part B Appl. Biomater."},{"key":"10.1016\/j.ijpharm.2017.02.035_bib0150","series-title":"Lacrimal Gland, Tear Film, and Dry Eye Syndromes 2: Basic Science and Clinical Relevance","author":"Sullivan","year":"2012"},{"key":"10.1016\/j.ijpharm.2017.02.035_bib0155","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.cis.2006.03.001","article-title":"Characterization of zero-valent iron nanoparticles","volume":"120","author":"Sun","year":"2006","journal-title":"Adv. Colloid Interface Sci."},{"key":"10.1016\/j.ijpharm.2017.02.035_bib0160","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2014.3192","article-title":"The pathophysiology and treatment of glaucoma: a review","volume":"311","author":"Weinreb","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.ijpharm.2017.02.035_bib0165","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nrd3745","article-title":"Ophthalmic drug discovery: novel targets and mechanisms for retinal diseases and glaucoma","volume":"11","author":"Zhang","year":"2012","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517317301254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517317301254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T20:08:55Z","timestamp":1568837335000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517317301254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":33,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0378517317301254"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2017.02.035","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced ocular efficacy of topically-delivered dorzolamide with nanostructured mucoadhesive microparticles","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2017.02.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}